Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.5 USD | +1.92% | +19.54% | -13.21% |
23/04 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
23/04 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.21% | 16.05B | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
+5.41% | 13.68B | |
+33.57% | 12.17B | |
-24.98% | 8.24B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Morgan Stanley Raises BeiGene's Price Target to $295 From $290, Maintains Overweight Rating